Living with and treating ATTR amyloidosis

Transthyretin amyloid cardiomyopathy is a condition that is caused by a buildup of abnormal protein deposits in the heart.

An overview of TTR stabilizers and gene-silencing therapies for treating hereditary transthyretin (hATTR) amyloidosis.

Why caregivers for people with this heart condition need to prioritize their health, including mental health.

Strategies to promote good communication among the different members of your healthcare team for FSGS.

For anyone living with FSGS, preventing these complications will be an important goal of treatment.

Strategies for managing stress and avoiding caregiver burnout when caring for a child with congenital adrenal hyperplasia.